Tokyo, July 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058313) titled 'Evaluating the efficacy of 10-color muli-parameter FCM-based MRD methods in acute myeloid leukemia' on July 7.
Study Type:
Observational
Primary Sponsor:
Institute - Kyushu University Hospital
Condition:
Condition - acute myeloid leukemia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Establishment of 10-color multi-parameter FCM-based MRD assay in AML
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - AML patients whose samples were preserved based on KCNET protocol in Kyushu University Hospital
Key exclusion criteria - Key exclusion criteria are defined by the preceding KCNET protocol
Target Size - 150
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2017 Year 07 Month 12 Day
Date of IRB - 2025 Year 04 Month 28 Day
Anticipated trial start date - 2017 Year 07 Month 12 Day
Last follow-up date - 2025 Year 04 Month 28 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066667
Disclaimer: Curated by HT Syndication.
